During an interview with Forbes, CEO and Founder of Ybrain, Kiwon Lee, said: “Our ambition is to challenge one of the toughest problems humanity faces today. Cancer is nearing a cure, but we don’t yet have a cure for Alzheimer’s, even with today’s most advanced medical technology.”
Ybrain’s device comprises of a headband with two sensors embedded in the front that transmits electronic signals to stimulate brain activity. Lee says the headband is a “very non-invasive form of brain stimulation” more favourable than taking pills.
Ybrain plans to tackle a series of degenerative neurological disorders, but also plans to help people who want to improve their normal neurological functioning by conditioning the brain to work at higher levels.
“Our patented headsets can be worn at home and monitored from a lab, and will help alleviate a series of neurological disorders, including addiction, trauma, dieting and schizophrenia,” said Lee. The startup is currently running clinical trials using the same technology to treat clinical depression and mild cognitive impairment (MCI).
Ybrain plans to release two devices, Brain Wellness and Brain Fullness, to treat disorders and enhance brain function, respectively.
Although the company has received approval from the Food and Drug Association (FDA) to start clinical trials, it’s currently pursuing Korea Food and Drug Association (KFDA) approval and plans to release their devices to the market by 2016.